Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
We'll run labs, review your goals, and tell you honestly whether this combination is right for you
Downregulation of the Arg/N-degron pathway sensitizes cancer cells to chemotherapy in vivo
Funding This review article received no external funding
The major hurdleslack of objective diagnostic biomarkers, the BBB impeding drug delivery, significant patient heterogeneity, and the need for more sensitive clinical trial endpointscollectively form a critical barrier to progress
in diabetic KK-A(y) mice
V., Fischbacher, U., Kirschbaum, C., Fehr, E
US$ 20.40
US$ 26.51
US$ 21.06
US$ 20.96
US$ 27.54
US$ 28.61
